查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1437516

羥嗪市場，按劑型、適應症類型、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Hydroxyzine Market, By Dosage Form, By Indication Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 289 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年羥嗪市場規模為2.133億美元，2024年至2032年CAGR為5.5%。

羥嗪市場-市場動態

過敏盛行率的上升推動了市場的成長

在過去的幾十年裡，全世界過敏和相關疾病的發生率增加。由於多種原因，出現過敏反應的人數正在增加。例如，最新更新於 2022 年 4 月的《過敏事實和數據》指出，過敏是美國慢性病的第六大常見原因，每年影響近 5,000 萬人。因此，該國過敏症盛行率很高，需要改進治療方案。對此，IJERPH 2021 年 11 月發表的一篇論文指出，儘管過敏的確切原因尚不清楚，但遺傳和環境因素對全球過敏性疾病的負擔有很大影響。此外，根據幾項研究，羥嗪可用於緩解過敏相關的搔癢。它是一種抗組織胺藥，其作用是在發生過敏反應時防止身體產生稱為組織胺的特定有機化合物。因此，越來越需要羥嗪來控制疾病負擔。因此，目標族群顯著的過敏負荷和羥嗪對過敏的治療優勢預計將推動市場擴張。

羥嗪市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 5.5% 左右的CAGR成長

根據劑型細分，片劑細分市場佔據主導地位，並可能在預測期內保持其主導地位

根據適應症類型細分，異位性接觸性皮膚炎細分市場預計將在預測期內佔據最大的市場佔有率

按地區分類，北美是 2023 年的主要收入來源

羥嗪市場-細分分析：

全球羥嗪市場根據劑型、適應症類型和地區進行細分。

市場依劑型分為四大類：膠囊劑、錠劑、注射劑和糖漿劑。平板電腦市場在市場上佔據主導地位，並可能在預測期內保持其主導地位。羥嗪等抗組織胺藥物很快就從消化系統吸收，口服後 15 至 30 分鐘開始顯示臨床效果。這些旨在減輕精神和神經疾病帶來的壓力和焦慮。它有助於手術前的睡眠。由於擴大使用片劑劑型來治療過敏性疾病和焦慮，以及神經系統疾病盛行率的增加，該類別正在不斷成長。

根據適應症類型，市場分為三類：蕁麻疹、組織胺介導的搔癢症和異位性接觸性皮膚炎。預計異位性接觸性皮膚炎細分市場在預測期內將佔據最大的市場佔有率。由於對羥嗪劑型的需求不斷成長以及異位性皮膚炎的盛行率不斷增加，市場收入增加。根據國際濕疹理事會 2022 年的數據，異位性皮膚炎非常普遍，影響高達 10% 的成人和 20% 的兒童。此外，在傷殘調整生命年評估的皮膚病中，疾病負擔排名第一，在非致命性疾病中排名第 15 位。

羥嗪市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。這些區域根據開展業務的國家進一步分類。預計北美將在 2023 年佔據最大市場佔有率，並且由於特應性接觸性皮膚炎的高發生率、完善的基礎設施以及對焦慮和神經障礙的認知不斷提高，預計在預測期內將繼續保持相同的模式療法，以及合約研究組織和製藥公司之間合作的增加。根據CDC 的數據，2019 年至2021 年間，所有年齡層成年人接受精神健康照護的比例從19.2% 上升至21.6%，18 歲至44 歲之間的個人接受精神健康照護的比例從18.5% 上升至23.2%。此外，女性18 至 44 歲人群中，比男性更有可能接受心理健康護理。

羥嗪市場-競爭格局：

市場上主要的參與者有Alliance Pharma PLC、OAK PHARMS INC.、Teva Pharmaceutical Industries、Piramal Healthcare UK Limited、輝瑞公司、上海瑞正化學科技有限公司、Lupin Pharmaceuticals, Inc.、葛蘭素史克公司、常州ComWin精細化學品有限公司、Impax Laboratories, Inc. 和諾華國際股份公司。這些參與者採取各種類型的策略來維持市場競爭力，例如產品發布、收購、擴張、批准、協議等。

最近的發展：

2022年12月，HPRA核准Brillpharma（愛爾蘭）將鹽酸羥嗪25毫克薄膜衣片商業化。這些擁有成人焦慮管理許可證。

目錄

第1章：羥嗪市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 羥嗪市場片段（按劑型）
    • 按適應症類型分類的羥嗪市場片段
    • 按國家/地區分類的羥嗪市場片段
    • 按地區分類的羥嗪市場片段
  • 競爭洞察

第 3 章：羥嗪主要市場趨勢

  • 羥嗪市場促進因素
    • 市場促進因素的影響分析
  • 羥嗪市場限制
    • 市場限制影響分析
  • 羥嗪市場機會
  • 羥嗪市場未來趨勢

第 4 章：羥嗪產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：羥嗪市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：羥嗪市場格局

  • 2023 年羥嗪市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：羥嗪市場 - 按劑型

  • 概述
    • 按劑型分類的細分市場佔有率分析
    • 膠囊
    • 平板電腦
    • 注射
    • 糖漿

第 8 章：羥嗪市場 - 依適應症類型

  • 概述
    • 按指標類型分類的細分市場佔有率分析
    • 蕁麻疹
    • 組胺介導的搔癢
    • 異位性接觸性皮膚炎

第 9 章：羥嗪市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美羥嗪主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按劑型）
    • 北美市場規模與預測（按適應症類型）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲羥嗪主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按劑型）
    • 歐洲市場規模和預測（按指示類型）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區羥嗪主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按劑型）
    • 亞太地區市場規模與預測（依適應症類型）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲羥嗪主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按劑型）
    • 拉丁美洲市場規模與預測（按適應症類型）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲羥嗪主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按劑型）
    • 中東和非洲市場規模及預測（按適應症類型）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章：主要供應商分析 - 羥嗪產業

  • 競爭儀表板
  • 公司簡介
    • Alliance Pharma PLC
    • OAK PHARMS INC.
    • Teva Pharmaceutical Industries
    • Piramal Healthcare UK Limited
    • Pfizer Inc.
    • Shanghai Ruizheng Chemical Technology Co., Ltd
    • Lupin Pharmaceuticals, Inc.
    • GlaxoSmithKline plc
    • Changzhou ComWin Fine Chemicals Co., Ltd
    • Impax Laboratories, Inc.
    • Novartis International AG

第 11 章：360 度分析師視角

第 12 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2234

REPORT HIGHLIGHT

Hydroxyzine Market size was valued at USD 213.30 Million in 2023, expanding at a CAGR of 5.5% from 2024 to 2032.

Hydroxyzine is an N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy) ethyl and (4-chlorophenyl) (phenyl)methyl groups respectively. It has a role as a H1-receptor antagonist, an anxiolytic drug, a dermatologic drug, an antipruritic drug and an anticoronaviral agent. It is an N-alkylpiperazine, a hydroxyether and a member of monochlorobenzenes.

Hydroxyzine Market- Market Dynamics

The rising prevalence of allergies drives market growth

Over the past several decades, there has been an increase in the frequency of allergies and associated disorders worldwide. The number of people experiencing allergic reactions is increasing for several reasons. As an illustration, Allergy Facts and Figures, which was last updated in April 2022, states that allergies account for the sixth most common cause of chronic disease in the United States, affecting almost 50 million individuals annually. As a result, the nation has a high prevalence of allergies, necessitating improved treatment alternatives. In this regard, a paper published in November 2021 in IJERPH states that, even though the exact causes of allergies are unclear, hereditary and environmental factors contribute significantly to the global burden of allergic illnesses. Furthermore, hydroxyzine may be utilized to relieve allergy-related itching, according to several studies. It is an antihistamine that functions by preventing the body from producing particular organic compounds known as histamine when an allergic response occurs. Thus, there is a growing need for hydroxyzine to control the burden of illness. As a result, the target population's significant allergy load and hydroxyzine therapeutic advantages for allergies are anticipated to drive market expansion.

Hydroxyzine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.5% over the forecast period (2024-2032)

Based on dosage form segmentation, the tablets segment dominates the market and is likely to maintain its dominance during the forecast period

Based on indication type segmentation, the atopic contact dermatitis segment is expected to hold the largest market share during the forecast period

Based on region, North America was the leading revenue generator in 2023

Hydroxyzine Market- Segmentation Analysis:

The Global Hydroxyzine Market is segmented based on Dosage form, Indication type and Region.

The market is divided into four categories based on dosage form: capsules, tablets, injections, and syrup. The tablet segment dominates the market and is likely to maintain its dominance during the forecast period. Antihistamine medications such as hydroxyzine are quickly absorbed from the digestive system and start to show clinical effects 15 to 30 minutes after oral administration. These are intended to reduce stress and anxiety brought on by mental and neurological disorders. It facilitates sleep before surgery. The category is growing due to the increasing use of tablet dosage forms for the treatment of allergic illnesses and anxiety, as well as an increase in the prevalence of neurological disorders.

The market is divided into three categories based on indication type: urticaria, histamine-mediated pruritus and atopic contact dermatitis. The atopic contact dermatitis segment is expected to hold the largest market share during the forecast period. The market's revenue has increased as a result of the growing demand for hydroxyzine dosage forms and the increasing prevalence of atopic dermatitis. As per the International Eczema Council 2022, atopic dermatitis is highly prevalent, impacting up to 10% of adults and 20% of children. Furthermore, the illness burden is ranked first for skin conditions evaluated in disability-adjusted life years and 15th globally for nonfatal disorders.

Hydroxyzine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to hold a maximum market share in 2023 and is expected to continue the same pattern during the forecast period due to the high frequency of atopic contact dermatitis, the availability of well-established infrastructure, the rising awareness of anxiety and nervous disorder therapies, and the rise in collaborations between contract research organizations and pharmaceutical corporations. According to the CDC, the proportion of people receiving mental health care went up from 19.2% to 21.6% for adults of all ages and from 18.5% to 23.2% for individuals between the ages of 18 and 44 between 2019 and 2021. Furthermore, women were more likely than males to undergo mental health care among people aged 18 to 44.

Hydroxyzine Market- Competitive Landscape:

The key players operating in the market are Alliance Pharma PLC, OAK PHARMS INC., Teva Pharmaceutical Industries, Piramal Healthcare UK Limited, Pfizer Inc., Shanghai Ruizheng Chemical Technology Co., Ltd, Lupin Pharmaceuticals, Inc., GlaxoSmithKline plc, Changzhou ComWin Fine Chemicals Co., Ltd, Impax Laboratories, Inc. and Novartis International AG. These players adopted various types of strategies to remain competitive in the market such as product launches, acquisitions, expansion, approvals, agreements and others.

Recent Developments:

In December 2022, the HPRA approved Brillpharma (Ireland) to commercialize Hydroxyzine hydrochloride 25 mg film-coated tablets. These have adult anxiety management licenses.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HYDROXYZINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alliance Pharma PLC

OAK PHARMS INC.

Teva Pharmaceutical Industries

Piramal Healthcare UK Limited

Pfizer Inc.

Shanghai Ruizheng Chemical Technology Co., Ltd

Lupin Pharmaceuticals, Inc.

GlaxoSmithKline plc

Changzhou ComWin Fine Chemicals Co., Ltd

Impax Laboratories, Inc.

Novartis International AG

GLOBAL HYDROXYZINE MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019 - 2032

  • Capsules
  • Tablets
  • Injections
  • Syrup

GLOBAL HYDROXYZINE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Urticaria
  • Histamine-Mediated Pruritus
  • Atopic Contact Dermatitis

GLOBAL HYDROXYZINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hydroxyzine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hydroxyzine Market Snippet by Dosage Form
    • 2.1.2. Hydroxyzine Market Snippet by Indication Type
    • 2.1.3. Hydroxyzine Market Snippet by Country
    • 2.1.4. Hydroxyzine Market Snippet by Region
  • 2.2. Competitive Insights

3. Hydroxyzine Key Market Trends

  • 3.1. Hydroxyzine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hydroxyzine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hydroxyzine Market Opportunities
  • 3.4. Hydroxyzine Market Future Trends

4. Hydroxyzine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hydroxyzine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hydroxyzine Market Landscape

  • 6.1. Hydroxyzine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hydroxyzine Market - By Dosage Form

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Dosage Form, 2023 & 2032 (%)
    • 7.1.2. Capsules
    • 7.1.3. Tablets
    • 7.1.4. Injections
    • 7.1.5. Syrup

8. Hydroxyzine Market - By Indication Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication Type, 2023 & 2032 (%)
    • 8.1.2. Urticaria
    • 8.1.3. Histamine-Mediated Pruritus
    • 8.1.4. Atopic Contact Dermatitis

9. Hydroxyzine Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Hydroxyzine Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Hydroxyzine Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Hydroxyzine Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Hydroxyzine Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Hydroxyzine Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication Type, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Hydroxyzine Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Alliance Pharma PLC
    • 10.2.2. OAK PHARMS INC.
    • 10.2.3. Teva Pharmaceutical Industries
    • 10.2.4. Piramal Healthcare UK Limited
    • 10.2.5. Pfizer Inc.
    • 10.2.6. Shanghai Ruizheng Chemical Technology Co., Ltd
    • 10.2.7. Lupin Pharmaceuticals, Inc.
    • 10.2.8. GlaxoSmithKline plc
    • 10.2.9. Changzhou ComWin Fine Chemicals Co., Ltd
    • 10.2.10. Impax Laboratories, Inc.
    • 10.2.11. Novartis International AG

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Hydroxyzine Market: Dosage Form Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Dosage Form
  • TABLE Global Hydroxyzine Market, by Dosage Form 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Indication Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication Type
  • TABLE Global Hydroxyzine Market, by Indication Type 2019-2032 (USD Million)
  • TABLE Hydroxyzine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Hydroxyzine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE North America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Europe Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Asia Pacific Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Latin America Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Dosage Form, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Hydroxyzine Market, by Indication Type, 2019-2032 (USD Million)